Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients

Fungal Infections in Leukemia Patients: How Do We Prevent and Treat Them?

(2010) Konstantinos Leventakos et al.   CLINICAL INFECTIOUS DISEASES

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

(2009) Johan Maertens et al.   CANCER

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

(2009) L. Pagano et al.   HAEMATOLOGICA

Changes in causes of death over time after treatment for invasive aspergillosis

(2008) John R. Wingard et al.   CANCER

Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia–Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study

(2008) Lennert Slobbe et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: AspergillusGalactomannan Index: A Surrogate End Point to Assess Outcome of Therapy?

(2008) Kieren A. Marr   CLINICAL INFECTIOUS DISEASES

Strong Correlation between Serum Aspergillus Galactomannan Index and Outcome of Aspergillosis in Patients with Hematological Cancer: Clinical and Research Implications

(2008) Marisa H. Miceli et al.   CLINICAL INFECTIOUS DISEASES

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis

(2008) C. Cordonnier et al.   CLINICAL MICROBIOLOGY AND INFECTION

Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock

(2008) Hye Yun Park et al.   LEUKEMIA & LYMPHOMA

Galactomannan on the stage: prospective evaluation of the applicability in routine practice and surveillance

(2008) Mine Durusu Tanriover et al.   MYCOSES